I-10% ye-Enrofloxacin Isisombululo somlomo
Ukuqamba
I-100ml iqulethe i-10g ye-Enrofloxacin
Imbonakalo
Le mveliso phantse ayinambala ukuya kulwelo olumthubi olucacileyo
Isenzo se-Pharmacological
I-Empagliflozin lichiza elibanzi le-bactericidal elinikezelwe kwi-fluoroquinolones.Inefuthe elihle kwi-Escherichia coli, Salmonella, Klebsiella, Brucella, Pasteurella, Actinobacillus pleuropneumoniae, Erysipelothrix, Proteus, Serratia marcescens, Corynebacterium pyogenes, Potter septicum, Staphylococcus aureus, Mycoplasmsaccus adocuptocus, Mycoplasma, Chlamycoccus, Pyogenes, Mycoplasma, Pyogenes kunye ne-Pyogenes. kunye nefuthe elibuthathaka kwibhaktheriya ye-anaerobic.Inempembelelo ebalulekileyo emva kwe-antibacterial kwiibhaktheriya ezithintekayo.Indlela yokusebenza ye-antibacterial yale mveliso kukuthintela i-bacterial DNA gyrase, iphazamise ukuphindaphinda, ukukhutshelwa kunye nokulungiswa kunye nokudityaniswa kwe-DNA yebhaktheriya, kwaye ibhaktheriya ayikwazi ukukhula kwaye iphindaphindeke ngokuqhelekileyo kwaye ife.
Pharmacokinetics
Le mveliso ifakwe kakuhle emva kokulawulwa komlomo kwizilwanyana ezininzi.I-bioavailability yokulawulwa komlomo kwiinkukhu yi-62.2% ~ 84%, esasazwa ngokubanzi kwiinkukhu kwaye inokungena kakuhle kwizicubu kunye nolwelo lomzimba (kubandakanywa namathambo).Ngaphandle kwe-cerebrospinal fluid, ukuxinwa kweziyobisi phantse kuzo zonke izihlunu kuphezulu kunoko kwiplasma.I-Hepatic metabolism ikakhulu ukususa iqela le-ethyl le-7-piperazine ring ukuvelisa i-ciprofloxacin, ilandelwa yi-oxidation kunye ne-glucuronic acid conjugation.Ininzi ikhutshwe yizintso (kunye ne-tubular secretion kunye ne-glomerular filtration), kwaye i-15% ukuya kwi-50% ikhutshwe ingatshintshi kumchamo.Ukupheliswa kobomi besiqingatha sale mveliso emva kokulawulwa komlomo kwiinkukhu yi-9.1 kwiiyure ze-14.2
Ukusebenzisana kweziyobisi
(1) Le mveliso inefuthe le-synergistic ngokudibanisa ne-aminoglycosides okanye i-penicillin ebanzi.
Ionini zetsimbi ezinzima ezifana neCa2 +, Mg2 +, Fe3 + kunye ne-Al3 + zinokutshiza ngale mveliso kwaye zichaphazele ukufunxa.
2
3
(4) Isenzo kunye nokusetyenziswa: Fluoroquinolone antibacterial drug.Isetyenziselwa izifo zebhaktheriya kunye nosulelo lwe-mycoplasma kwiinkukhu.
Umthamo kunye nolawulo
Isiselo esixutywe: 0.5 ~ 0.75 ml yenkukhu nge-1 L yamanzi.
Ukusabela kakubi
(1) Ukuwohloka kwe-cartilage kwenzeka kwizilwanyana ezincinci, ezichaphazela ukukhula kwamathambo kwaye kubangela ukuqhwala kunye neentlungu.
(2) Iimpendulo zenkqubo yokugaya ziquka ukulahlekelwa ngumdla, isifo sohudo, njl.
Ukulumkela
I-contraindicated ekubekeni iinkukhu ngexesha lokubeka
Ixesha lokurhoxisa
I-Avian: iintsuku ezisi-8
Ugcino
Itywinwe kwaye igcinwe, ikhuselwe ekukhanyeni.
I-Hebei Veyong Pharmaceutical Co., Ltd, yasekwa kwi-2002, ehlala kwisiXeko saseShijiazhuang, kwiPhondo laseHebei, eChina, ecaleni kwe-Capital Beijing.Ulishishini elikhulu leyeza lezilwanyana eliqinisekisiweyo le-GMP, eline-R&D, imveliso kunye nokuthengiswa kwee-APIs zonyango lwezilwanyana, amalungiselelo, ukutya okuxutywe kwangaphambili kunye nezongezo zokutya.NjengeZiko lobuGcisa lePhondo, iVeyong iye yaseka inkqubo yeR&D ehlaziyiweyo yeyeza elitsha lezilwanyana, kwaye lishishini elaziwa kuzwelonke leteknoloji esekelwe kunyango lwezilwanyana, kukho iingcali zobugcisa ezingama-65.I-Veyong ineziseko ezimbini zokuvelisa: i-Shijiazhuang kunye ne-Ordos, apho isiseko se-Shijiazhuang sihlanganisa indawo ye-78,706 m2, kunye neemveliso ze-API ze-13 ezibandakanya i-Ivermectin, i-Eprinomectin, i-Tiamulin Fumarate, i-Oxytetracycline hydrochloride ects, kunye ne-11, i-injection oral solutions, i-injection oral solutions. , i-premix, i-bolus, i-pesticides kunye ne-disinfectant, njl.IVeyong ibonelela ngee-APIs, ngaphezulu kwe-100 yamalungiselelo eleyibhile, kunye nenkonzo ye-OEM & ODM.
I-Veyong ibona ukubaluleka okukhulu kulawulo lwenkqubo ye-EHS(Environment, Health & Safety), kwaye ifumene i-ISO14001 kunye nezatifikethi ze-OHSAS18001.I-Veyong idweliswe kumashishini amashishini asakhasayo anobuchule kwiPhondo laseHebei kwaye inokuqinisekisa ukubonelela ngokuqhubekayo kweemveliso.
I-Veyong yaseka inkqubo epheleleyo yolawulo lomgangatho, yafumana isatifikethi se-ISO9001, isatifikethi se-GMP sase-China, isiqinisekiso se-APVMA se-GMP sase-Australia, isatifikethi se-GMP sase-Ethiopia, isatifikethi se-Ivermectin CEP, kwaye siphumelele ukuhlolwa kwe-US FDA.I-Veyong ineqela lobuchwephesha lobhaliso, intengiso kunye nenkonzo yobugcisa, inkampani yethu ifumene ukuthembela kunye nenkxaso kubathengi abaninzi ngomgangatho wemveliso ogqwesileyo, umgangatho ophezulu wokuthengisa kwangaphambili kunye nenkonzo yasemva kokuthengisa, ulawulo olunzulu kunye nolwenzululwazi.I-Veyong yenze intsebenziswano yexesha elide kunye namashishini amaninzi amachiza ezilwanyana awaziwayo ngamazwe ngamazwe kunye neemveliso ezithunyelwa eYurophu, eMzantsi Melika, kuMbindi Mpuma, e-Afrika, e-Asia, njl. ngaphezu kwamazwe angama-60 kunye nemimandla.